(FM) Oncología
Departamento académico
University of Western Australia
Perth, AustraliaPublicacions en col·laboració amb investigadors/es de University of Western Australia (5)
2022
2016
-
SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer
Journal of Clinical Oncology, Vol. 34, Núm. 15, pp. 1723-1731
2014
-
Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: Quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine
Annals of Oncology, Vol. 25, Núm. 7, pp. 1428-1436
-
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: The SIRFLOX study
BMC Cancer, Vol. 14, Núm. 1
2012
-
Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial
The Lancet, Vol. 380, Núm. 9839, pp. 358-365